As Boston Scientific prepares to report Q3 2026 results before the market open on October 28, congressional trading disclosures show lawmakers positioning across several names tied to imminent earnings. Rep. Kevin Hern recorded five trades in BSX along with five in Home Depot ahead of its November 17 release, according to the latest filings. The Oklahoma Republican also appears in trades for IQV in healthcare, energy names OKE and DVN, and industrials EMR and ITW, creating exposure across multiple sectors preparing for quarterly updates.
Analyst consensus points to BSX delivering adjusted EPS near $0.77 on roughly $5.2 billion in revenue, compared with $0.75 EPS and $5.07 billion in the prior-year quarter. The company beat estimates in Q2 and maintains full-year guidance of $3.28 to $3.32 adjusted EPS. HD carries expectations around $3.87 EPS on revenue near $42.7 billion, up from $3.74 EPS and $41.35 billion last year. These upcoming reports arrive against a backdrop of recent BSX developments including a guidance trim and a cybersecurity incident that some reports indicate may pressure near-term results.
The earnings watchlist extends to four trades in AAPL involving Hern, Cleo Fields and Pete Sessions, plus two trades in JPM by Sen. Sheldon Whitehouse. A separate group of 26 trades lists Hern alongside Suzan K. DelBene, Max Miller, Richard Blumenthal and Donald Sternoff Beyer. The data shows no clear split between buys and sells in the summarized filings, yet the concentration before specific reporting dates stands out. Total activity across the ten entries exceeds 50 trades, marking elevated engagement at a time when corporate guidance and sector trends could drive volatility.
This pattern of overlap between filing dates and earnings calendars continues to draw attention from retail investors monitoring congressional portfolios. BSX has shown resilience through prior beats while HD faces mixed recent performance relative to consensus. With energy and industrial names also appearing in Hern's activity, the filings reflect a diversified approach rather than isolated bets. Public sentiment tracked on X highlights the BSX guidance adjustment and cyber event as factors that could influence the print, though analyst coverage remains robust with more than 20 firms publishing estimates.
The timing of these disclosures raises questions about how lawmakers allocate attention across the earnings calendar, particularly in healthcare where innovation cycles meet macro pressures and in retail where consumer spending data looms large. Further filings in coming weeks could clarify whether this represents sustained positioning or tactical moves ahead of the reports.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.